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Abstract 
Insulin resistance is commonly associated with obesity and noninsulin-dependent diabetes. Whereas it 
predicts the development of diabetes, its effect on body weight change is unknown. We measured 
glucose disposal rates at submaximally- and maximally-stimulating insulin concentrations in 192 
nondiabetic Pima Indians and followed their weight change over 3.5±1.8 y (mean±SD). 
Results: (a) Insulin-resistant subjects gained less weight than insulin-sensitive subjects (3.1 vs. 7.6 kg, P < 
0.0001). (b) The percent weight change per year correlated with glucose disposal at submaximally- (r = 
0.19, P < 0.01) and maximallystimulating (r = 0.34, P < 0.0001) insulin concentrations independent of sex, 
age, initial weight, and 24-h energy expenditure; the correlations were stronger for glucose oxidation than 
for glucose storage. (c) Weight gain was associated with an increase in insulin resistance more than four 
times that predicted from the cross-sectional data. 
We conclude that insulin resistance is associated with a reduced risk of weight gain in nondiabetic Pima 
Indians. 
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Insulin Resistance Associated with Lower Rates of Weight Gain in Pima Indians
Boyd A. Swinbum, Bulangu L. Nyomba, Mohammed F. Saad, Francesco Zurlo, Itamar Raz,
William C. Knowler, Stephen Lillioja, Clifton Bogardus, and Eric Ravussin
Clinical Diabetes and Nutrition Section and the Diabetes and Arthritis and Epidemiology Section, Phoenix Epidemiology and Clinical
Research Branch, National Institute ofDiabetes andDigestive andKidney Diseases, National Institutes ofHealth, Phoenix, Arizona 85016
Abstract
Insulin resistance is commonly associated with obesity and
noninsulin-dependent diabetes. Whereas it predicts the develop-
ment of diabetes, its effect on body weight change is unknown.
We measured glucose disposal rates at submaximally- and
maximally-stimulating insulin concentrations in 192 nondia-
betic Pima Indians and followed their weight change over
3.5±1.8 y (mean±SD).
Results: (a) Insulin-resistant subjects gained less weight
than insulin-sensitive subjects (3.1 vs. 7.6 kg, P < 0.0001). (b)
The percent weight change per year correlated with glucose
disposal at submaximally- (r = 0.19, P < 0.01) and maximally-
stimulating (r = 0.34, P < 0.0001) insulin concentrations inde-
pendent of sex, age, initial weight, and 24-h energy expendi-
ture; the correlations were stronger for glucose oxidation than
for glucose storage. (c) Weight gain was associated with an
increase in insulin resistance more than four times that pre-
dicted from the cross-sectional data.
We conclude that insulin resistance is associated with a
reduced risk of weight gain in nondiabetic Pima Indians. (J.
Clin. Invest. 1991. 88:168-173.) Key words: obesity- insulin
resistance * glucose oxidation - weight gain * noninsulin-depen-
dent diabetes mellitus
Introduction
Decreased insulin-mediated glucose disposal (insulin resis-
tance) is found in virtually all patients with noninsulin-depen-
dent diabetes mellitus (NIDDM)' (1, 2), and is a significant
predictor of the disease in Pima Indians (3). Insulin resistance
is also commonly associated with obesity, and probably repre-
sents the mechanism by which obesity exerts its influence on
the development of NIDDM. However, the relationship, if
any, of insulin resistance to change in weight is not known.
The Pima Indians of Arizona are very prone to NIDDM
and obesity (4) and are insulin-resistant compared to Cauca-
sians ofthe same body mass index (5). It is possible that insulin
resistance could accelerate body weight gain, thereby predis-
posing to obesity as well as NIDDM. Indeed, it has been
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previously suggested that insulin resistance, or the consequent
hyperinsulinemia, may cause obesity via inhibition of lipolysis
(6), reduced thermic effect offood (7), or increased appetite (8).
This would imply a positive feedback relationship, whereby
insulin resistance induced by weight gain would tend to in-
crease further weight gain.
On the other hand, there is evidence in Pima Indians that a
low rate ofglucose to lipid oxidation (low respiratory quotient)
is associated with a reduced rate of weight gain (9). Because a
low rate ofglucose oxidation contributes to a low overall rate of
glucose disposal (oxidation plus storage), insulin resistance
may also be associated with a reduced rate of weight gain.
To further examine this issue, we measured the glucose
disposal rates in 192 nondiabetic Pima Indians and followed
their weight change over a mean period of 3.5 yr. We found
that insulin-resistant subjects gained less weight than insulin-
sensitive subjects.
Methods
Subjects. The subjects were Pima Indians living in the Gila River In-
dian Community in Arizona. They were participating in a longitudinal
study of the development ofNIDDM and obesity which included an-
nual admissions to a metabolic research ward. Subjects were in good
health as assessed by medical history, physical examination, and rou-
tine tests. All subjects gave informed consent and the studies were ap-
proved by the ethics committees of the National Institutes of Health,
the Indian Health Service, and the Tribal Council of the Gila River
Indian Community. During each 8-16-d admission to the metabolic
ward, subjects were fed a weight-maintenance diet (50% of calories as
carbohydrate, 30% as fat, and 20% as protein). Body composition was
estimated by underwater weighing (10, 11). Body fat distribution was
assessed by the waist:thigh circumference ratio. A minimum of2 d after
admission, all subjects underwent a 75-g oral glucose tolerance test. Ifa
diagnosis of diabetes was made according to National Diabetes Data
Group criteria (12), data from that and subsequent admissions were
excluded from the analysis for that subject. This was done to avoid any
bias that weight loss from glycosuria or therapeutic diets may have on
the results. 195 subjects had at least one follow-up admission 6 mo or
more after the initial admission. Three subjects were deleted as outliers:
one subject had an intentional weight loss of 12.5% in 1 yr, andtwo had
very large weight gains (41 and 48 kg), each of these values being > 4
SD from the respective group mean. Therefore, 192 subjects who had a
total of 673 follow-up admissions were used for the analyses. Weight
change between the first and the last admission was used for all analyses
except the survival analysis in which each admission was considered
separately. Of the 192 subjects, 109 also had 24-h energy expenditure
measured in a respiratory chamber during admission, and these results
were adjusted for individual differences in fat-free mass, fat mass, age,
and sex as previously described (13). Euglycemic clamp data from the
last admission were available in 124 of the subjects.
Hyperinsulinemic, euglycemic clamp. After 8-15 d, a two-step hy-
perinsulinemic, euglycemic clamp was performed by a modification of
the method ofDeFronzo et al. (14) as previously described (15). Briefly,
3-3H-glucose was infused for 220 min and hepatic glucose production
was estimated at 100-120 min and at 200-220 min (16). Insulin, at a
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low dose (40 mU/[body surface area in square meters] per minute), was
infused from 120-220 min, then at a high dose (400 mU/m2 per min)
from 220-320 min while euglycemia was maintained with a variable
infusion of 20% dextrose. During the last 40 min of the low-dose and
high-dose infusions, the mean (±SD) insulin concentrations were
910±265 pM (mean coefficient of variation [CV.] = 5.7±5.6%) and
14,420±3,760 pM (C.V. = 7.1±11.7%), respectively, and the mean glu-
cose concentrations were 5.2±0.3 mM (C.V. = 2.3± 1.0%) and 5.2±0.3
mM (C.V. = 2.8±1.1%), respectively. Insulin-mediated glucose dis-
posal at submaximally- (SubmaxM) and maximally-stimulating
(MaxM) insulin concentrations were calculated from the 40-min pe-
riods as described (14, 15).
To account for differences in metabolic size among subjects, glu-
cose disposal rates were divided by estimated metabolic body size
(EMBS; fat-free body mass + 17.7 kg) as described elsewhere (17), and
then adjusted for the steady-state plasma glucose concentration (18).
Concurrent, continuous, indirect calorimetry was performed with a
clear, plastic, ventilated hood system (15) to estimate the rates of lipid
and glucose oxidation. Nonoxidative carbohydrate disposal (or glucose
storage) was calculated as the difference between total glucose disposal
and glucose oxidation. Plasma glucose concentrations were measured
by the glucose oxidase method (analyzer, Beckman Instruments, Inc.,
Fullerton, CA). Plasma insulin concentrations were determined by the
Herbert modification (19) ofthe radioimmunoassay ofYalow and Ber-
son (20).
Statistical methods. Statistical analyses were performed with the
procedures of the SAS Institute (Cary, NC). We examined the effect of
insulin resistance on weight change by three different approaches: (a)
The residuals ofthe linear relationship between MaxM and initial body
weight were calculated for each subject as the difference between the
measured value and the value predicted on the basis ofthe population
regression line. The mean weight change (in kilograms) was compared
between those with positive residuals (i.e., a high MaxM for their
weight) and those with negative residuals (i.e., a low MaxM for their
weight). A nonparametric test (Wilcoxon rank sum) was used to test for
differences between the groups because the distributions ofsome ofthe
variables were not normal within each group. The correlation between
the actual residual values and percent weight change per year was also
examined. (b) The relationships between SubmaxM and MaxM and
weight change were examined by simple correlations (Pearson product-
moment) and by linear regression analysis to determine if the relation-
ships were dependent upon age, sex, or total 24-h energy expenditure.
Weight change was expressed as percent weight change per year to
minimize the confounding effects of different initial weights and fol-
low-up periods. (c) The effects ofSubmaxM and MaxM on weight gain
(independent of age, sex, and initial weight) were also assessed by sur-
vival analysis using Cox's proportional hazards model (21). This analy-
sis determines the incidence of reaching a set "failure" point, in this
case arbitrarily defined as 5, 10, or 15 kg ofweight gain. Because all the
variables used in these analyses satisfied the proportional hazards as-
sumptions, as described by Harrel (21), the ratio of rates of "failing"
could be derived between any two values ofSubmaxM or MaxM. We
used the 10th and 90th percentile values.
The correlations between SubmaxM and MaxM and weight change
were also assessed under certain conditions to check for biases in the
results. (a) The exclusion of subjects after the diagnosis of diabetes (n
= 16) may have introduced some selection bias against insulin-resis-
tant, weight-gaining subjects. Reanalysis was performed with these sub-
jects included (up to the admission associated with their greatest body
weight). (b) Since subjects with impaired glucose tolerance (2-h glucose
7.8-11 mM) may have received advice to lose weight, reanalysis was
performed only on subjects with normal glucose tolerance (n = 126). (c)
The possibility ofspurious correlations arising from repeated measure-
ments in the same subject was examined by using the means ofthe first
and last values for SubmaxM and MaxM (n = 124) in place of the
initial values as suggested by Oldham (22). (d) To check that the corre-
lation was not dependent on short-term fluctuations in body weight,
the minimum follow-up period was increased from 6 mo to 2 yr
(n= 144).
Results
The physical and metabolic characteristics of the subjects are
shown in Tables I and II. The subjects (104 males and 88 fe-
males) were on average overweight, although a wide range of
percent body fat (8-51 %) was represented. Over a mean follow-
up period of 3.5 yr (0.6-6.9 yr), 148 subjects had a positive and
44 had a zero or negative weight change (mean weight change
5.4±7.8 kg, mean±SD, P < 0.0001).
Comparison of insulin-sensitive and insulin-resistant sub-
jects. The relationship between glucose disposal at the high-
dose insulin infusion (MaxM) and initial body weight is shown
in Fig. 1 (r = -0.38, P < 0.0001). We examined the subsequent
weight change in those subjects above the regression line (i.e.,
insulin-sensitive for their body weight) and those below the
regression line (i.e., insulin-resistant for their body weight) (Ta-
ble III). The insulin-resistant subjects were older, had higher
insulin concentrations before and during the oral glucose toler-
ance test, and had less than half the weight gain of the insulin-
sensitive subjects (3.1 vs. 7.6 kg, P < 0.0001). During the study,
three subjects (one male, two females) of the insulin-sensitive
group and 13 subjects (four males, nine females) ofthe insulin-
resistant group developed NIDDM. There was a significant
correlation between the residual values (deviation from the re-
Table I. Physical Characteristics and Follow-up Data on 192 Nondiabetic Pima Indians
Male Female All
(n= 104) (n= 88) (n= 192)
Initial data
Age (yr) 25.5+0.5 (18-39) 25.0±0.6 (18-41) 25.2±0.4
Weight (kg) 97.4±2.7 (50-181) 91.2±2.2 (48-170) 94.6±1.8
Body fat (%) 29±1 (8-48)* 40±1 (25-51) 34±1
Body mass index (kg/M2) 33+1 (18-60)t 36±1 (20-63) 34±1
Follow-up data
Duration (yr) 3.7±0.2 (0.6-6.9) 3.2±0.2 (0.7-6.7) 3.5±0.1
5.0±0.8 (-14.8- 5.8±0.8 (-10.8-
Weight change (kg) 26.5) 32.1) 5.4±0.6
% weight change/yr 1.6±0.3 (-8.3-14.3) 2.4±0.3 (-6.6-14.6) 2.0±0.2
Values are means±SEM with ranges in parentheses. * P < 0.001 males vs. females. $ P < 0.05 males vs. females.
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Table II. Insulin-mediated Glucose Disposal at Low (SubmaxM) and High (MaxM) Insulin Concentrations
in 192 Nondiabetic Pima Indians
Male Female All
(n= 104) (n= 88) (n= 192)
Basal hepatic glucose production 2.4±0.1 (1.6-3. 1)* 2.6±0.1 (1.8-3.7) 2.4±0.01
Low-dose insulin infusion
(40 mU/m2.* min)
Total (SubmaxM) 3.0±0.1 (1.4-6.5)t 2.6±0.1 (1.6-4.2) 2.8±0.1
Oxidation 1.9±0.1 (0.5-3.4)§ 2.1±0.1 (1.1-3.3) 2.0±0.1
Storage 1.1±0.1 (-0.1-3.7)* 0.5±0.1 (-0.7-2.1) 0.8±0.1
High-dose insulin infusion
(400 mU/m2* min)
Total (MaxM) 9.0±0.2 (4.2-14.1) 8.7±0.2 (5.0-12.9) 8.9±0.1
Oxidation 3.3±0.1 (1.7-4.8)§ 3.5±0.1 (2.0-4.8) 3.4±0.1
Storage 5.7±0.2 (1.8-8.8)$ 5.2±0.2 (1.7-9.2) 5.5±0.1
Values are means±SEM ranges in parentheses. Glucose disposal rates in mg/kg EMBS* min. EMBS = fat-free mass + 17.7 kg (17).
* P < 0.0001; t P < 0.01; § P = 0.05 for male vs. female comparisons.
gression line) and the percent weight change per year (r = 0.36,
P < 0.0001). The correlations were similar if the relationships
were calculated for males only (r = 0.39, P < 0.0001) or females
only (r = 0.38, P < 0.001).
Correlations between glucose disposal and weight change.
The absolute weight change (kilograms) over the study period
was significantly correlated with initial weight (r = 0.18, P
< 0.05) and length offollow-up (r = 0.20, P < 0.01). Therefore,
to minimize the effects of varying durations of follow-up and
different initial body weights, we expressed weight change as a
percentage weight change per year (which was not correlated
with initial weight) for the remainder of the correlation analy-
ses. This rate of percent weight change was significantly corre-
lated with SubmaxM (Table IV, r = 0. 19, P < 0.01) and MaxM
(Table IV and Fig. 2, r = 0.34, P < 0.0001). The change in
weight was more closely related to glucose oxidation than to
glucose storage (Table IV), despite the fact that total glucose
disposal is more highly correlated with glucose storage (r
= 0.83, P < 0.0001 for SubmaxM; r = 0.95, P < 0.0001 for
MaxM) than with glucose oxidation (r = 0.59, P < 0.0001 for
SubmaxM; r = 0.60, P < 0.0001 for MaxM).
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Figure 1. Correlation between glucose disposal at maximum-stimu-
lating insulin concentrations (MaxM) and initial body weight in 104
male (A) and 88 female (-) nondiabetic Pima Indians (r = -0.38, P
< 0.0001, ,B = -0.03 mg/kgEMBS* min per kg). Subjects above the
regression line (n = 95) gained (mean) 7.6 kg and those below the
line (n = 97) gained 3.1 kg (P < 0.0001) over 3.5 yr. EMBS = fat-free
mass + 17.7 kg (17). 24 observations hidden.
< 0.01), total area under the insulin curve during an oral glu-
cose tolerance test (r = -0.21, P < 0.01), but was not correlated
with the glucose area under the curve (r = -0.1 1, NS), fasting
insulin (r = -0.1 1, NS), fasting glucose (r = -0.05, NS), or
waist:thigh ratio (r = -0.14, NS). When these variables were
analyzed in multiple linear regression models with either Sub-
maxM or MaxM, the predictors of weight gain were higher
SubmaxM (P < 0.05), younger age (P < 0.05), and female sex
(P < 0.05) in one model (r2 = 0.09, P < 0.001), and higher
MaxM (P < 0.0001), younger age (P = 0.08), and female sex (P
< 0.05) in the other (r2 = 0.15, P < 0.0001). The group was
divided into "less obese" and "more obese" according to the
mean initial weight for each sex. The effect of SubmaxM and
MaxM on weight change was stronger in the less obese group (P
< 0.05, P < 0.0001) than in the more obese group (P = NS, P
< 0.02). In the subgroup of 109 subjects in whom data from the
respiratory chamber were available, the effect ofSubmaxM (P
< 0.05) and MaxM (P < 0.05) on the percent weight change per
year was independent of age, sex, and the 24-h energy expendi-
ture adjusted for fat-free mass, fat mass, age, and sex.
When the correlation analyses were checked for possible
biases (see Methods for details), the relationships between Sub-
maxM and MaxM and the rate of weight change were main-
tained. (a) Inclusion of 16 subjects after the diagnosis of dia-
betes (r = 0.22, P < 0.01; r = 0.33, P < 0.0001, respectively, for
SubmaxM and MaxM, n = 192). (b) Only normal glucose toler-
ant subjects used (r = 0.22, P < 0.05; r = 0.36, P < 0.0001, n
= 126). (c) Mean, rather than initial, values for SubmaxM and
MaxM used (r = 0.18, P < 0.05; r = 0.23, P< 0.05, n = 124). (d)
Follow-up periods of < 2 yr excluded (r = 0.19, P < 0.05; r
- 0.38, P < 0.0001, n = 144).
Survival analysis of weight gain. Survival analysis (using
the proportional hazards model) examines the cumulative inci-
dence of reaching a predefined "failure" point. We defined
three "failure" points: 5 kg, reached by 107 subjects; 10 kg
reached by 58 subjects; and 15 kg reached by 30 subjects.
MaxM was a significant predictor of weight change (indepen-
dent of initial weight, age, and sex) at 5 kg (P < 0.01), 10 kg (P
< 0.01), and 15 kg (P < 0.01), whereas SubmaxM was signifi-
cant at 10 kg (P < 0.05), borderline at 15 kg (P = 0.05), but not
at 5 kg (P = 0. 12). The hazard rate ratios for "failure" at 10 kg
between the 90th percentile (SubmaxM = 4.1, MaxM = 11.5
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Table III. Initial and Follow-up Parameters of192 Nondiabetic Pima Indians Divided into Insulin-sensitive and Insulin-resistant Groups
Insulin-sensitive Insulin-refistant
(56M/39F) (48M/49F) P value
Initial parameters
Age (yr) 23.9±0.5 (18-37) 26.7±0.6 (18-41) <0.001
Weight (kg) 93.4±2.5 (48-166) 95.8+2.5 (50-181) 0.52
Body fat (%) 33±1 (8-51) 34±1 (12-50) 0.32
SubmaxM (mg/kgEMBS min)* 3.2±0.1 (1.6-6.5) 2.3±0.1 (1.4-4.8)
MaxM (mg/kgEMBS min)* 10.3±0.1 (7.4-14.1) 7.3±0.1 (4.2-9.0)
Fasting insulin (pM) 220±10 (65-446) 324±17 (79-863) <0.0001
OGTT insulin (pM. 3 h)$ 1021±63 (198-3257) 1797±104 (489-5400) <0.0001
Fasting glucose (mM) 5.1±0.1 (4.2-5.9) 5.3±0.1 (4.2-6.9) <0.01
OGTT glucose (mM- 3 h)* 6.5±0.1 (4.6-9.0) 7.5±0.1 (4.7-10.7) <0.0001
Follow-up parameters
Follow-up duration (yr) 3.5±0.2 (0.6-6.9) 3.5±0.2 (0.8-6.5) 0.73
Weight change (kg) 7.6±0.8 (-9.8-32.1) 3.1±0.7 (-14.8-20.4) <0.0001
Values are means±SEM with ranges in parentheses. * Glucose disposal rates. These values are different between groups by experimental design.
Insulin concentrations (mean±SD) during clamp for insulin-sensitive and insulin-resistant groups: SubmaxM 856±256, 965±263 pM (P
< 0.01). MaxM 13990±3540, 14840±3940 pM (P = NS). EMBS = fat-free mass + 17.7 kg (17). $ Mean concentration throughout oral glucose
tolerance test.
mg/kgEMBS - min) and the tenth percentile (SubmaxM = 1.9,
MaxM = 6.1 mg/kgEMBS * min) were 3.8 (95% confidence in-
terval 1.7-8.6) for MaxM and 2.2 (95% C.I. 1.0-4.9) for Sub-
maxM. The hazard rate ratio is the ratio ofthe hazards (rates of
"failure" per person per time) in subjects at two levels of a
predictor variable. It is approximately equal to the cumulative
incidence (or risk) ratio at various periods of follow-up. Thus,
the risk of a person with a low MaxM (6.1 mg/kgEMBS * min)
gaining 10 kg is about one-quarter to one-third that ofa person
with a high MaxM (1 1.5 mg/kgEMBS - min). This is shown in
Fig. 3 with the middle group representing the overall group
mean.
Table IV. Simple Correlations between Initial Parameters and
Subsequent Weight Change in 192 Nondiabetic Pima Indians
Independent variable r P
Age (yr) -0.22 <0.01
Initial weight (kg) -0.01 NS
Body fat (%) 0.03 NS
Waist/thigh ratio -0.14 NS
Fasting insulin (pM) -0.11 NS










Total (MaxM) 0.34 <0.0001
Oxidation 0.29 <0.0001
Storage 0.23 <0.01
Dependent variable = percent weight change/year. * EMBS = fat-free
mass+ 17.7 kg (17).
Change in weight and change in insulin sensitivity. 124 sub-
jects had a euglycemic clamp during their final admission
(mean insulin concentrations±SD were 1,008±337 for Sub-
maxM and 16,900±4,650 pM for MaxM). The relationship
between the change in weight (kilograms) and the changes in
insulin action were r = -0.40 (P < 0.0001) for SubmaxM and r
= -0.52 (P < 0.0001) for MaxM (Fig. 4). When one subject
(indicated by asterisk in the figure) was deleted as an outlier,
the latter relationship was stronger (r = -0.57, P < 0.0001, n
= 123). The slope ofthe relationship (in mg/kgEMBS - min per
kg body wt) between change in weight and change in MaxM
was steeper (,6 = -0.134, n = 124) than that of the cross-sec-
tional relationship ofweight and MaxM (# = -0.030, n = 192).
Discussion
This group of 192 nondiabetic Pima Indians gained a signifi-
cant amount of weight over 3.5 yr of follow-up, but the more
insulin-resistant subjects gained the least. Insulin resistance,
whether or not it was corrected for the initial body weight, was
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Figure 2. Correlation between glucose disposal at maximum-stimu-
lating insulin concentrations (MaxM) and the percent weight change
per year in 104 male (-) and 88 female (m) nondiabetic Pima Indians
(r = 0.34, P < 0.0001, ft = 0.55). EMBS = fat-fiee mass + 17.7 kg
(17). 24 observations hidden.
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Figure 3. The effect of three different values of glucose disposal at
maximum-stimulating insulin concentrations (MaxM) on the cumu-
lative incidence of a 10-kg weight gain calculated from 192 nondia-
betic Pima Indians. The upper line (i) represents the 90th percentile
ofMaxM (1 1.5 mg/kgEMBS * min), the middle line (.) represents the
mean (8.9 mg/kgEMBS - min), and the lower line (A) represents the
10th percentile (6.1 mg/kgEMBS - min). The hazard rate ratio of a
10-kg weight gain is 3.8 (95% confidence interval 1.7-8.6) comparing
the 90th and the 10th percentile of MaxM. EMBS = fat-free mass
+ 17.7 kg (17).
ity. This relationship was independent of age, sex, and 24-h
energy expenditure.
These findings are contrary to the hypothesis suggesting
that insulin resistance, or its consequent hyperinsulinemia,
predisposes to obesity. Based on in vivo and in vitro fat cell
studies, Arner (6) postulated that the hyperinsulinemia ofinsu-
lin resistance would suppress insulin-sensitive lipolysis in the
adipocyte, thereby leading to further fat accumulation. Felig
(7) hypothesized that resistance to the insulin-mediated compo-
nent of the thermogenic effect of food could lead to weight
gain. However, this component is only a small fraction of the
total 24-h energy expenditure, and there is even considerable
controversy about whether such a defect exists in insulin-resis-
tant individuals (23). The effect of insulin on hunger and food
intake has attracted considerable research, largely in animals,
over the last 30 years (24). Some investigators have found that
insulin stimulates food intake (8, 25), whereas others have
found insulin suppresses it (26).
The current study examines the effect of insulin resistance
on weight change in a longitudinal manner in humans. The
Pima Indians are an obese population, and the vast majority of
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Figure 4. Correlation between the change in glucose disposal at max-
imum-stimulating insulin concentrations (MaxM) and the change in
weight in 59 male (-) and 65 female (.) nondiabetic Pima Indians
(r = -0.52, P < 0.0001, # = -0.134 mg/kgEMBS min per kg).
Elimination of the outlier (*) strengthened the correlation (r = -0.57,
P <0.0001, # = -0.143 mg/kgEMBS * min per kg). EMBS = fat-free
mass + 17.7 kg (17). Eight observations hidden.
insulin resistance on weight change will be seen in more
weight-stable populations is not known.
The reliability of the tracer technique employed in this
study to determine hepatic glucose production has been ques-
tioned (27). Errors in the estimation ofhepatic glucose produc-
tion during the low-dose infusion will add to the imprecision of
SubmaxM as a measurement. MaxM, on the other hand, is
measured at a supraphysiological insulin concentration which
completely suppresses hepatic glucose production making it a
more accurate measurement. This may explain why MaxM
was more powerful than SubmaxM at predicting weight change
in almost all analyses.
Insulin resistance is the third metabolic predictor ofweight
change to be described in this population, the other two being
resting metabolic rate (28) and respiratory quotient (9). All
three parameters show the same patterns in relationship to
body weight. Obese people tend to have high absolute resting
metabolic rates, low respiratory quotients (i.e., higher ratio of
fat:carbohydrate oxidation), and insulin resistance in cross-sec-
tional analysis. On the contrary, in longitudinal analysis, a low
relative resting metabolic rate, a high respiratory quotient, and
insulin sensitivity are associated with weight gain; in other
words the directions of the relationships with body weight are
reversed. Furthermore, a change in body weight itself is asso-
ciated with a change in insulin sensitivity, such that weight gain
results, on average, in greater insulin resistance. The slope of
the change in insulin sensitivity for the change in body weight
(-0.134 mg/kgEMBS*min per kg) is 4.5 times steeper than
the cross-sectional slope between insulin sensitivity and body
weight (-0.030 mg/kgEMBS * min per kg). Therefore, weight
gain is associated with increased insulin resistance beyond that
which can be explained by the cross-sectional data. Again, this
is similar to the patterns seen with the increased resting meta-
bolic rate (28) and decreased respiratory quotient (9) associated
with weight gain. This suggests the possibility of a negative
feedback relationship whereby an increase in weight causes a
somewhat exaggerated increase in insulin resistance which in
turn serves to slow down the rate of weight gain.
This proposed interaction helps to explain some ofthe find-
ings in this study which may appear contradictory. If weight
gain causes insulin resistance, how can some individuals who
are clearly overweight be quite insulin sensitive? It may be that
those overweight individuals experienced some weight loss be-
fore their first admission, and this resulted in them being some-
what more insulin sensitive for their weight at the beginning of
the study. During the follow-up period, they had a much higher
chance of gaining weight than those who perhaps experienced
some weight gain (and "exaggerated" insulin resistance) before
the first admission.
Also, if the insulin resistance induced by weight gain does
attenuate further weight gain, how can the presence ofsuch an
obese, yet insulin-resistant population like the Pimas (5) be
explained? Although we have shown that insulin sensitivity
predicts weight gain, clearly it cannot be the major driving
force for the widespread gross obesity in the population be-
cause of its apparent negative feedback relationship with
weight gain. However, in the presence of some major energy
imbalance (such as a hypercaloric diet, decreased physical activ-
ity), we would speculate that the degree ofinsulin resistance or
insulin sensitivity may have a modulating effect on body
weight, thereby limiting the impact of large changes in energy
balance on body weight. This modulating effect may be weaker
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in the more obese subjects who are closer to the lower physolog-
ical limits of insulin sensitivity.
By what mechanisms might insulin resistance limit weight
gain? Glucose oxidation was a stronger predictor of weight
change than was glucose storage or insulinemia. This implies
that the mechanisms may involve the control ofglucose oxida-
tion, and this is supported by the finding that a low 24-h respira-
tory quotient (an independent measurement of a low glucose
oxidation relative to lipid oxidation) is associated with a slower
rate ofweight gain (9). Because glucose and lipid oxidation are
closely reciprocally related, it may be the control oflipid oxida-
tion which is important and the glucose oxidation rates are
simply reciprocal reflections (29). However, this is less likely
because glucose oxidation seems to take priority over lipid oxi-
dation, especially during and after meals (30). Mechanisms
which lower glucose oxidation would have two important ef-
fects on energy balance: (a) the reciprocal increase in fat oxida-
tion needed to meet energy demands would limit fat storage;
(b) a higher proportion ofa given oral carbohydrate load tend-
ing to be directed to storage as glycogen rather than to oxida-
tion, perhaps thereby diminishing the signals for food intake
(31, 32). In his paper, Flatt proposed that insulin resistance
represents a mechanism which tends to limit further increase in
adipase tissue mass (31). Although insulin resistance, as we
measured it using the euglycemic clamp, manifests as defects in
both glucose oxidation and glucose storage, Felber et al. (33)
have shown that under more physiological conditions, the de-
fect in glucose oxidation is dominant. The higher glucose and
insulin responses to oral glucose seen in insulin-resistant sub-
jects overcomes the deficit in glucose storage, whereas the defi-
cit in glucose oxidation remains.
We conclude that within this weight-gaining population of
nondiabetic Pima Indians, insulin resistance is associated with
a lower rate ofbody weight gain and, more specifically, it seems
that low glucose oxidation secondary to weight gain may atten-
uate further weight gain.
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